Trial Profile
Phase I Evaluation of 131I-J591 Murine Monoclonal Antibody in Patients With Progressive Androgen-Independent Prostate Cancer.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs J 591-radiolabelled (Primary)
- Indications Prostate cancer
- Focus Adverse reactions
- 16 Jun 2009 Planned end date (Mar 2002) added as reported by ClinicalTrials.gov.
- 16 Jun 2009 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 03 Oct 2005 New trial record.